Amicus Therapeutics, Inc (FOLD)

PHARMACEUTICAL PREPARATIONS

Amicus Therapeutics, Inc (FOLD) was listed on Nasdaq from May 31, 2007 and stopped trading under the symbol FOLD on April 28, 2026.

Listed On
Nasdaq
Listed Since
May 31, 2007
Stopped Trading
April 28, 2026
Employees
511

About Amicus Therapeutics, Inc

Amicus Therapeutics Inc is a biotechnology company focused to develop and deliver transformative medicines for people living with rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Institutional ownership

In 13F filings for the quarter ended June 30, 2026, 3 institutions reported holding FOLD, with 797 shares worth $11,548 in aggregate. The largest reported holder was Ifp Advisors, with 796 shares worth $11,534. Of the 3 largest holders listed below, 1 reduced its position, 1 held its position unchanged and 1 sold out during the quarter.

InstitutionSharesValueQuarter change
Ifp Advisors796$12KReduced 2.21%
Huntington National Bank1$14Unchanged
Janus Henderson (Jupiter Topco)Sold out

Form 13F is a quarterly report that institutional investment managers with at least $100 million in qualifying securities file with the SEC. It lists long positions as of the last day of the quarter and is due within 45 days of quarter end, so these holdings describe that date rather than today.

Frequently asked questions

What is FOLD?

Amicus Therapeutics, Inc (FOLD) was listed on Nasdaq from May 31, 2007 and stopped trading under the symbol FOLD on April 28, 2026.

Who are the largest institutional holders of FOLD?

In 13F filings for the quarter ended June 30, 2026, the largest reported holders of FOLD were Ifp Advisors, Huntington National Bank and Janus Henderson (Jupiter Topco).

How many institutions own FOLD?

3 institutions reported a position in FOLD for the quarter ended June 30, 2026, worth $11,548 in total.

Did institutions buy or sell FOLD last quarter?

Of the 3 largest reported holders, 1 reduced its position, 1 held its position unchanged and 1 sold out during the quarter. Every reported holder and its change is on the SentiSense ownership page for FOLD.

Every reported institutional holder, plus insider and congressional trades in FOLD, on SentiSense.